Crm stock forecast analysts highlight CRM stock forecast

Analysts highlight CRM stock forecast potential to outperform the NASDAQ average, driven by strategic acquisitions in marketing cloud services. Price is testing upper Bollinger Bands. Among recent announcements, the expanded commitment from Gilead Sciences and Merck to Vault CRM stands out as highly relevant, showing a strengthening trend of top global pharmaceutical groups choosing Veeva’s platform to drive commercial execution. This supports the company’s near-term narrative around multi-product suite adoption and broadens Veeva's recurring revenue opportunities, an important catalyst amid increasing competition and innovation cycles. See analysts’ growth forecasts and price target for Salesforce stock (It’s free!) >>> CRM stock forecast indicates sustained uptrend as Salesforce expands generative AI features, creating new monetization avenues. MACD histogram shows increasing bullish divergence.